The PE Ratio as of November 2024 (TTM) for Silo Pharma, Inc. (SILO) is -0.75

According to Silo Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.75. This represents a change of -36.33% compared to the average of -1.18 of the last 4 quarters.

Silo Pharma, Inc. (SILO) Historical PE Ratio (quarterly & annually)

How has SILO PE Ratio performed in the past?

The mean historical PE Ratio of Silo Pharma, Inc. over the last ten years is -9.32. The current -0.75 PE Ratio has changed 704.34% with respect to the historical average. Over the past ten years (40 quarters), SILO's PE Ratio was at its highest in in the December 2015 quarter at 651.93. The PE Ratio was at its lowest in in the December 2014 quarter at -90.02.

Silo Pharma, Inc. (SILO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Silo Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Silo Pharma, Inc. (SILO) Average PE Ratio

How has SILO PE Ratio performed in the past?

The current PE Ratio of Silo Pharma, Inc. (SILO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Silo Pharma, Inc. (SILO) PE Ratio vs. Peers

How is SILO’s PE Ratio compared to its peers?

Silo Pharma, Inc.’s PE Ratio is less than Protagenic Therapeutics, Inc. (-0.52), greater than Rezolute, Inc. (-4.94), greater than Lumos Pharma, Inc. (-1.03), greater than Anebulo Pharmaceuticals, Inc. (-4.78), less than Sino Biopharmaceutical Limited (15.19), greater than Inventiva S.A. (-1.25), greater than BioCardia, Inc. (-0.83), greater than UroGen Pharma Ltd. (-4.45), less than Indaptus Therapeutics, Inc. (-0.64), less than Tempest Therapeutics, Inc. (-0.66), less than Comera Life Sciences Holdings, Inc. (-0.00), greater than Forte Biosciences, Inc. (-0.86), greater than Pardes Biosciences, Inc. (-1.36), less than Shattuck Labs, Inc. (-0.69), greater than Eliem Therapeutics, Inc. (-2.42), greater than Champions Oncology, Inc. (-18.21), greater than Century Therapeutics, Inc. (-0.79), greater than Acumen Pharmaceuticals, Inc. (-1.74), less than HOOKIPA Pharma Inc. (-0.62), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than Inozyme Pharma, Inc. (-1.84), greater than Terns Pharmaceuticals, Inc. (-5.12),

Build a custom stock screener for Silo Pharma, Inc. (SILO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silo Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silo Pharma, Inc. (SILO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silo Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.